This page shows NYMTZ (NYMTZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet expansion is the core mechanic here, with FY2025 earnings recovering as a larger financed asset base finally produced cash.
Over the last two years, total assets climbed from$7.4B to$12.6B . With equity still near$1.4B , ROA was only1.2% , so the much stronger ROE reflects leverage turning modest asset returns into a healthier equity result rather than a richly profitable asset base on its own.
Cash conversion improved sharply in FY2025: operating cash flow of
Asset growth still leans on external financing, with total liabilities at
Financial Health Signals
We are recalculating NYMTZ's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
NYMTZ passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, NYMTZ generates $0.90 in operating cash flow ($134.0M OCF vs $149.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
NYMTZ earns $0.3 in operating income for every $1 of interest expense ($137.8M vs $452.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
NYMTZ generated $601.9M in revenue in fiscal year 2025. This represents an increase of 50.0% from the prior year.
NYMTZ's EBITDA was $160.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 403.1% from the prior year.
NYMTZ reported $149.0M in net income in fiscal year 2025. This represents an increase of 340.3% from the prior year.
NYMTZ earned $1.10 per diluted share (EPS) in fiscal year 2025. This represents an increase of 196.5% from the prior year.
Cash & Balance Sheet
NYMTZ generated $125.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 1290.3% from the prior year.
NYMTZ held $210.3M in cash against $735.8M in long-term debt as of fiscal year 2025.
NYMTZ had 90M shares outstanding in fiscal year 2025. This represents a decrease of 0.1% from the prior year.
Margins & Returns
NYMTZ's operating margin was 22.9% in fiscal year 2025, reflecting core business profitability. This is up 46.1 percentage points from the prior year.
NYMTZ's net profit margin was 24.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 40.2 percentage points from the prior year.
NYMTZ's ROE was 10.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.9 percentage points from the prior year.
Capital Allocation
NYMTZ spent $1.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 57.0% from the prior year.
NYMTZ invested $8.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 66.9% from the prior year.
NYMTZ Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $172.1M+0.8% | $170.7M+6.3% | $160.6M+14.0% | $140.9M+8.6% | $129.7M+9.7% | $118.3M+9.1% | $108.4M+19.4% | $90.8M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $24.5M-2.5% | $25.1M+7.5% | $23.3M+98.1% | $11.8M-5.1% | $12.4M+3.2% | $12.0M+0.7% | $11.9M+2.5% | $11.6M |
| Operating Income | $86.7M+54.0% | $56.3M+42.6% | $39.5M+822.8% | $4.3M-88.7% | $37.7M+218.6% | -$31.8M-174.3% | $42.8M+280.2% | -$23.7M |
| Interest Expense | $123.7M-3.0% | $127.5M+2.8% | $124.0M+18.8% | $104.5M+8.1% | $96.6M+5.6% | $91.5M+3.9% | $88.1M+22.9% | $71.7M |
| Income Tax | $159K+461.4% | -$44K+85.2% | -$298K-85.1% | -$161K-124.8% | $648K+142.6% | -$1.5M-165.4% | $2.3M+579.8% | $342K |
| Net Income | $48.6M-9.2% | $53.5M+19.4% | $44.8M+424.5% | $8.5M-79.7% | $42.2M+234.3% | -$31.4M-173.3% | $42.8M+374.9% | -$15.6M |
| EPS (Diluted) | $0.40 | N/A | $0.36+1000.0% | $-0.04-112.1% | $0.33 | N/A | $0.36+224.1% | $-0.29 |
NYMTZ Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.8B+1.2% | $12.6B+1.9% | $12.4B+17.5% | $10.6B+5.5% | $10.0B+8.5% | $9.2B+3.5% | $8.9B+8.2% | $8.2B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $208.9M-0.7% | $210.3M+13.5% | $185.3M+15.5% | $160.4M-9.4% | $177.1M+5.8% | $167.4M-14.2% | $195.1M-17.2% | $235.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $22.4M0.0% | $22.4M0.0% | $22.4M | N/A | N/A | $0 | N/A | N/A |
| Total Liabilities | $11.3B+1.1% | $11.2B+1.9% | $11.0B+20.1% | $9.2B+6.6% | $8.6B+10.0% | $7.8B+5.0% | $7.4B+9.9% | $6.8B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $669.5M-9.0% | $735.8M-4.0% | $766.6M+17.4% | $653.0M-0.2% | $654.4M+14.2% | $573.2M-18.0% | $699.4M-12.6% | $800.7M |
| Total Equity | $1.5B+2.1% | $1.4B+2.6% | $1.4B+0.7% | $1.4B-1.5% | $1.4B+0.5% | $1.4B-3.4% | $1.4B+0.9% | $1.4B |
| Retained Earnings | -$1.4B+1.1% | -$1.4B+1.5% | -$1.4B+0.8% | -$1.4B-1.6% | -$1.4B+0.8% | -$1.4B-4.3% | -$1.4B+1.0% | -$1.4B |
NYMTZ Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$16.7M-126.9% | $62.1M+797.0% | $6.9M-82.4% | $39.2M+51.9% | $25.8M-11.3% | $29.1M+3257.9% | -$922K+7.2% | -$993K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $3.5M-54.8% | $7.6M+1.0% | $7.6M |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $25.7M+399.8% | -$8.6M0.0% | -$8.6M |
| Investing Cash Flow | -$67.0M+54.8% | -$148.1M+90.7% | -$1.6B-343.1% | -$360.0M+54.7% | -$794.2M-35.9% | -$584.3M+29.9% | -$834.1M-45.8% | -$572.1M |
| Financing Cash Flow | $106.7M-18.3% | $130.6M-91.9% | $1.6B+416.3% | $313.5M-56.1% | $713.8M+29.3% | $552.2M-30.9% | $798.8M+45.1% | $550.5M |
| Dividends Paid | $21.4M+3.0% | $20.8M+15.0% | $18.1M-0.5% | $18.2M-1.6% | $18.5M+1.9% | $18.1M0.0% | $18.1M-0.7% | $18.2M |
| Share Buybacks | $5.0M | $0 | $0-100.0% | $1.5M | $0 | $0 | $0-100.0% | $3.5M |
NYMTZ Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 50.4%+17.4pp | 33.0%+8.4pp | 24.6%+21.5pp | 3.0%-26.0pp | 29.1%+56.0pp | -26.9%-66.4pp | 39.5%+65.6pp | -26.2% |
| Net Margin | 28.2%-3.1pp | 31.4%+3.5pp | 27.9%+21.8pp | 6.1%-26.4pp | 32.5%+59.0pp | -26.5%-66.1pp | 39.5%+56.7pp | -17.2% |
| Return on Equity | 3.3%-0.4pp | 3.8%+0.5pp | 3.2%+2.6pp | 0.6%-2.4pp | 3.0%+5.3pp | -2.3%-5.2pp | 3.0%+4.1pp | -1.1% |
| Return on Assets | 0.4%-0.0pp | 0.4%+0.1pp | 0.4%+0.3pp | 0.1%-0.3pp | 0.4%+0.8pp | -0.3%-0.8pp | 0.5%+0.7pp | -0.2% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.46-0.1 | 0.52-0.0 | 0.55+0.1 | 0.470.0 | 0.47+0.1 | 0.41-0.1 | 0.48-0.1 | 0.56 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | 21.7%+29.6pp | -7.9%+1.5pp | -9.4% |
Frequently Asked Questions
What is NYMTZ's annual revenue?
NYMTZ (NYMTZ) reported $601.9M in total revenue for fiscal year 2025. This represents a 50.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NYMTZ's revenue growing?
NYMTZ (NYMTZ) revenue grew by 50% year-over-year, from $401.3M to $601.9M in fiscal year 2025.
Is NYMTZ profitable?
Yes, NYMTZ (NYMTZ) reported a net income of $149.0M in fiscal year 2025, with a net profit margin of 24.8%.
What is NYMTZ's EBITDA?
NYMTZ (NYMTZ) had EBITDA of $160.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does NYMTZ have?
As of fiscal year 2025, NYMTZ (NYMTZ) had $210.3M in cash and equivalents against $735.8M in long-term debt.
What is NYMTZ's operating margin?
NYMTZ (NYMTZ) had an operating margin of 22.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is NYMTZ's net profit margin?
NYMTZ (NYMTZ) had a net profit margin of 24.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is NYMTZ's return on equity (ROE)?
NYMTZ (NYMTZ) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NYMTZ's free cash flow?
NYMTZ (NYMTZ) generated $125.9M in free cash flow during fiscal year 2025. This represents a 1290.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is NYMTZ's operating cash flow?
NYMTZ (NYMTZ) generated $134.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are NYMTZ's total assets?
NYMTZ (NYMTZ) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are NYMTZ's capital expenditures?
NYMTZ (NYMTZ) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is NYMTZ's debt-to-equity ratio?
NYMTZ (NYMTZ) had a debt-to-equity ratio of 0.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NYMTZ's return on assets (ROA)?
NYMTZ (NYMTZ) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NYMTZ's Piotroski F-Score?
NYMTZ (NYMTZ) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NYMTZ's earnings high quality?
NYMTZ (NYMTZ) has an earnings quality ratio of 0.90x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can NYMTZ cover its interest payments?
NYMTZ (NYMTZ) has an interest coverage ratio of 0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.